Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

139
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
139
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organ damage in systemic sclerosis: linking immune activation, vasculopathy, and fibrosis to precision treatment.

Expert review of clinical immunology·2026
Same author

Whole-exome sequencing in hypertensive emergency with kidney disease.

Kidney international·2026
Same author

Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated Cardiomyopathy.

European journal of heart failure·2026
Same author

MSpine: a prospective longitudinal study of spinal cord lesions in multiple sclerosis: MRI monitoring and prognostic factors for active disease. A study protocol.

Neurological research and practice·2026
Same author

Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange.

Journal of translational autoimmunity·2026
Same author

Thrombotic Microangiopathy During Pregnancy: Role of Soluble Fms-like Tyrosine Kinase-1-Placental Growth Factor Ratios.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025

Related Experiment Video

Updated: May 20, 2025

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

11.1K

Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis.

Judith Potjewijd1, Rachid Tobal1, Steven J Arends1

  • 1Department of Internal Medicine, Division of Clinical & Experimental Immunology, CARIM, Maastricht University Medical Center, Maastricht, The Netherlands.

Rheumatology (Oxford, England)
|March 25, 2025
PubMed
Summary

Prostaglandin E1 (PGE1) treatment significantly increased endothelial progenitor cell (EPC) levels, including colony-forming unit-endothelial cells (CFU-ECs) and endothelial colony-forming cells (ECFCs), in systemic sclerosis (SSc) patients. This suggests PGE1 aids vascular repair in SSc patients with Raynaud's phenomenon.

Keywords:
RaynaudSScendothelial cellsendothelial progenitor cellsprostaglandin E1vascular repair

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

10.9K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K

Related Experiment Videos

Last Updated: May 20, 2025

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

11.1K
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

10.9K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K

Area of Science:

  • Vascular Biology
  • Immunology
  • Regenerative Medicine

Background:

  • Systemic sclerosis (SSc) involves microvascular injury and impaired angiogenesis, with dysfunctional endothelial progenitor cells (EPCs).
  • EPC subsets like CFU-ECs and ECFCs are crucial for vascular repair but are reduced in SSc patients.
  • The therapeutic potential of Prostaglandin E1 (PGE1) on EPCs in SSc remains unexplored.

Purpose of the Study:

  • To investigate PGE1's effect on EPC numbers (CFU-ECs and ECFCs) in SSc patients with Raynaud's phenomenon (RP).
  • To evaluate PGE1's potential role in promoting vascular repair in SSc.

Main Methods:

  • Evaluated PGE1's impact on EPC levels in 12 SSc patients with RP and 5 healthy controls (HCs).
  • Quantified CFU-EC and ECFC clusters pre- and post-intravenous PGE1 treatment (8-9 days).
  • Utilized standardized culture methods and statistical analyses to compare EPC counts between groups and time points.

Main Results:

  • SSc patients exhibited significantly lower baseline CFU-EC and ECFC counts compared to HCs.
  • PGE1 treatment significantly increased CFU-EC and ECFC clusters in SSc patients, normalizing levels to those of HCs.
  • A significant difference in EPC cluster count changes was observed between SSc patients and HCs post-treatment.

Conclusions:

  • PGE1 treatment effectively restores CFU-EC and ECFC levels in SSc patients.
  • These findings indicate PGE1's therapeutic potential in repairing vascular damage associated with SSc microvasculopathy.
  • PGE1 offers benefits beyond vasodilation, supporting its consideration for SSc treatment.